Close X
Get more out of
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.

Click here if you're interested
Helping you make better health choices

What Doctors Don't Tell You

In shops now or delivered to your home from only £4.25 an issue!

October 2020 (Vol. 5 Issue 7)

The use of Zantac for Maintenance Therapy

About the author: 

The use of Zantac for Maintenance Therapy image

In Vol 4 No 4 you state that our product Zantac is not approved for maintenance therapy in the US but is in the UK


In Vol 4 No 4 you state that our product Zantac is not approved for maintenance therapy in the US but is in the UK. I enclose a copy of the Physician's Desk Reference which contains a section on maintenance therapy in duodenal ulcers. The UK Datasheet for Zantac does not, as you state, emphasize that the drug should mainly be used for no longer than 12 weeks; it provides recommended dosages for various conditions which may take up to 12 weeks to heal.

The Datasheet then recommends maintenance treatment at reduced dosage when necessary, particularly in those with a history of recurrent ulcer. I enclose a copy of a published paper on the safety and efficacy of long term maintenance threatment with ranitidine.

In the UK we now provide patient information with the packaging for Zantac Tablets, including a section on side effects. You may also be aware that, like all pharmaceutical companies, we are allowed to provide the full Datasheet to patients on request. D D L Higson, Associate Medical Director, Glaxo Laboratories Ltd......

WDDTY replies:

Although we were referring to maintenance therapy for gastric ulcer, which is not approved in the US, thank you for clarifying the position. The Data Sheet Compendium is a bit less restrictive about Zantac's use as a maintenance treatment; however, it does make explicit or implicit the drug's use over a short term for most conditions other than duodenal ulcers.

We note the study you've sent (Alimen Pharma Ther (1992) 6, 629-645) provides persuasive evidence that of 464 patients with duodenal ulcer receiving maintenance treatment with ranitidine, 81 per cent were free from ulcer recurrence after nine years.

We have two problems with it. The first is that it only addresses efficacy, with little mention of safety. Our second reservation is it was funded by your company. Other studies refute these findings: in a study by Jensen et al (Gastroenterology 1990; 98; Suppl: A65) of chronic ulcer patients over three years, ranitidine was superior to a placebo in preventing rebleeding, although the rate of rebleeding in patients taking ranitidine was considerable (9 per cent vs 36 per cent in the placebo group).

We hope that you will notify UK patients of what the US Food and Drug Administration characterized as false and misleading promotional and advertising material for Zantac in violation of the federal Food, Drug and Cosmetic Act.

In the 5 May issue of the Journal of the American Medical Association, James H Lewis, MD, the vice president of medical development marketed products, published an open letter admitting that 1) studies haven't proved that Zantac works better than any other antiulcer drug; 2) the charts Glaxo has been using to show that Zantac is safer than other ulcer drugs haven't taken into account real experience with side effects or important information about drug interactions, such as that between Zantac and warfarin; 3) simply because lots of studies have been done on Zantac it doesn't follow that the drug is safer than other anti ulcer drugs.

Parkinson's and sinemet image

Parkinson's and sinemet

Choking on medicine image

Choking on medicine

You may also be interested in...

Support WDDTY

Help support us to hold the drugs companies, governments and the medical establishment accountable for what they do.


Latest Tweet


Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions..

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

© 2010 - 2020 WDDTY Publishing Ltd.
All Rights Reserved